Updated Jul 16, 2026
Osterloh Albert Frederick IV has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Albert Frederick Osterloh IV is a corporate executive known for his role as a director at Dexcom Inc, a company specializing in continuous glucose monitoring systems for diabetes management. His involvement in the company contributes to its strategic direction and governance.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | DXCM | DEXCOM INC | A — Grant or award | 1.6K | $0.00 | |
| 2026-02-26 | DXCM | DEXCOM INC | A — Grant or award | 7.1K | $0.00 |
Albert Frederick Osterloh IV is a corporate executive known for his role as a director at Dexcom Inc, a company specializing in continuous glucose monitoring systems for diabetes management. His involvement in the company contributes to its strategic direction and governance.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Osterloh Albert Frederick IV profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.